1,974
Views
14
CrossRef citations to date
0
Altmetric
Review

Viral hepatitis vaccination during pregnancy

, , , &
Pages 894-902 | Received 31 Aug 2015, Accepted 11 Dec 2015, Published online: 13 May 2016

References

  • http://www.who.int/hiv/mediacentre/news/whd2015preventhepatitis/en/.
  • World Health Organization. Towards the elimination of Hepatitis B and C by 2030: the draft WHO global hepatitis strategy, 2016-2021 and global elimination targets. 2015.
  • Swamy GK, Heine RP. Vaccinations for Pregnant Women. Obstet Gynecol 2015; 125:212-26; PMID:25560127; http://dx.doi.org/10.1097/AOG.0000000000000581
  • Datta SK, Bhatla N, Burgess MA, Lehtinen M, Bock HL. Women and vaccinations from smallpox to the future, a tribute to a partnership benefiting humanity for over 200 years. Hum Vaccin 2009; 5:450-4; PMID:19458487; http://dx.doi.org/10.4161/hv.8805
  • Yu WB, Grubor-Bauk B, Mullick R, Das S, Gowans EJ. Vaccination for pregnant women: Need to address. Hum Vaccin Immunother 2014; 10:3576-8; PMID:25483684; http://dx.doi.org/10.4161/hv.34343
  • Immunization during pregnancy. ACOG technical bulletin number 160-October 1991. Int J Gynaecol Obstet 1993; 40:69-79; PMID:8094357; http://dx.doi.org/10.1016/0020-7292(93)90778-U
  • Swamy GK, Garcia-Putnam R. Vaccine-Preventable Diseases in Pregnancy. Am J Perinatol 2013; 30:89-97; PMID:23271378
  • Makris MC, Polyzos KA, Mavros MN, Athanasiou S, Rafailidis PI, Falagas ME. Safety of Hepatitis B, Pneumococcal Polysaccharide and Meningococcal Polysaccharide Vaccines in Pregnancy A Systematic Review. Drug Saf 2012; 35:1-14; PMID:22149417; http://dx.doi.org/10.2165/11595670-000000000-00000
  • Hubka TA, Wisner KP. Vaccinations recommended during pregnancy and breastfeeding. J Am Osteopath Assoc 2011; 111:S23-30; PMID:22086892
  • Celikel A, Ustunsoz A, Guvenc G. Determination of vaccination status of pregnant women during pregnancy and the affecting factors. J Clin Nurs 2014; 23:2142-50; PMID:23815510; http://dx.doi.org/10.1111/jocn.12351
  • O'Donoghue K, Byrne BM. Antenatal detection of abnormal liver function tests - a marker for poor perinatal outcome. J Obstet Gynaecol 2000; 20:475-8; PMID:15512630; http://dx.doi.org/10.1080/014436100434631
  • Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003; 10:61-9; PMID:12558914; http://dx.doi.org/10.1046/j.1365-2893.2003.00398.x
  • Dahiya M, Kumar A, Kar P, Gupta RK, Kumar A. Acute viral hepatitis in third trimester of pregnancy. Indian J Gastroenterol 2005; 24:128-9; PMID:16041115
  • Magriples U. Hepatitis in pregnancy. Semin Perinatol 1998; 22:112-7; PMID:9638905; http://dx.doi.org/10.1016/S0146-0005(98)80043-8
  • Fiore S, Savasi V. Treatment of viral hepatitis in pregnancy. Expert Opin Pharmacother 2009; 10:2801-9; PMID:19929703; http://dx.doi.org/10.1517/14656560903304071
  • Hepatitis in pregnancy. ACOG Technical Bulletin Number 174-November 1992. Int J Gynaecol Obstet 1993; 42:189-98; PMID:7901073; http://dx.doi.org/10.1016/0020-7292(93)90638-D
  • American Academy of Pediatrics Committee on Infectious Disease. Hepatitis A vaccine recommendations. Pediatrics 2007; 120:189-99; PMID:17606579; http://dx.doi.org/10.1542/peds.2007-1088
  • Floreani A. Hepatitis C and pregnancy. World J Gastroenterol 2013; 19:6714-20; PMID:24187446; http://dx.doi.org/10.3748/wjg.v19.i40.6714
  • Almashhrawi AA, Ahmed KT, Rahman RN, Hammoud GM, Ibdah JA. Liver diseases in pregnancy: diseases not unique to pregnancy. World J Gastroenterol 2013; 19:7630-8; PMID:24282352; http://dx.doi.org/10.3748/wjg.v19.i43.7630
  • Elinav E, Ben-Dov IZ, Shapira Y, Daudi N, Adler R, Shouval D, Ackerman Z. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 2006; 130:1129-34; PMID:16618407; http://dx.doi.org/10.1053/j.gastro.2006.01.007
  • Ryu HS, Park SY, Lim SR, Kim HI, Kee WJ, Lee GS, Hong GY, Cho SB, Choi SK, Rew JS. Clinical characteristics and gestational complications associated with acute hepatitis a in pregnancy. Korean J Gastroenterol 2010; 56:307-13; PMID:21099238; http://dx.doi.org/10.4166/kjg.2010.56.5.307
  • Briem H, Safary A. Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later. J Med Virol 1994; 44:443-5; PMID:7897378; http://dx.doi.org/10.1002/jmv.1890440424
  • Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, Suntayakorn S, Suknuntapong T, Safary A, Tang DB. Protection against hepatitis A by an inactivated vaccine. Jama 1994; 271:1328-34; PMID:8158817; http://dx.doi.org/10.1001/jama.1994.03510410040030
  • Puntaric D, Baklaic Z, Ljubicic M, Vodopija I. Protection of adolescents against hepatitis A. Lijec vjesn 1996; 118:241-3; PMID:9132523
  • Van Herck K, Van Damme P. Prevention of hepatitis A by Havrix: a review. Expert Rev Vaccines 2005; 4:459-71; PMID:16117704; http://dx.doi.org/10.1586/14760584.4.4.459
  • Zhang S. Safety observation of attenuated live hepatitis B vaccine (H2 strain) in humans. Chin Med J 1990; 70:682-4
  • Cheng NL. Immunological effects of live attenuated hepatitis A vaccine. Chin Med J 1992; 72:581-3
  • Mao JS, Chai SA, Xie RY, Chen NL, Jiang Q, Zhu XZ, Zhang SY, Huang HY, Mao HW, Bao XN, et al. Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans. Vaccine 1997; 15:944-7; PMID:9261939; http://dx.doi.org/10.1016/S0264-410X(96)00304-0
  • Zhuang FC, Qian W, Mao ZA, Gong YP, Jiang Q, Jiang LM, Chen NL, Chai SA, Mao JS. Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program. Chin Med J (Engl) 2005; 118:1851-6; PMID:16313838
  • Faridi MM, Shah N, Ghosh TK, Sankaranarayanan VS, Arankalle V, Aggarwal A, Sathiyasekaran M, Bhattacharya N, Vasanthi T, Chatterjee S, et al. Immunogenicity and safety of live attenuated hepatitis A vaccine: a multicentric study. Indian pediatr 2009; 46:29-34; PMID:19179715
  • Bhave S, Ghosh A, Sapru A, Mitra Mmmc, Chatterjee S, Bhattacharya N, et al. Immunogenicity and safety of live attenuated hepatitis A vaccine (Biovac-A™) in healthy Indian children. Vaccine Development & Therapy 2014:1-5; PMID:25454852
  • Wacholder S, Chen BE, Wilcox A, Macones G, Gonzalez P, Befano B, Hildesheim A, Rodríguez AC, Solomon D, Herrero R, et al. Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. BMJ 2010; 340:c712; PMID:20197322; http://dx.doi.org/10.1136/bmj.c712
  • Moro PL, Museru OI, Niu M, Lewis P, Broder K. Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women. Am J Obstet Gynecol 2014; 210:561.e1-6; PMID:24378675; http://dx.doi.org/10.1016/j.ajog.2013.12.036
  • http://www.cdc.gov/vaccines/programs/vfc/providers/resolutions.html.
  • http://www.nhfpc.gov.cn/zwgkzt/pzxgzgh/200804/33518.shtml.
  • World Health Orgnization. Hepatitis A vaccines -June 2012. Weekly Epid Record 2012; 87:261-76
  • General recommendations on immunization-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60:1-64
  • Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-23
  • Munoz FM, Englund JA. A step ahead - Infant protection through maternal immunization. Pediatr Clin North Am 2000; 47:449-63; PMID:10761514; http://dx.doi.org/10.1016/S0031-3955(05)70217-0
  • Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, Irving S, Craig Cheetham T, Nakasato C, Glanz JM, et al. Vaccinations given during pregnancy, 2002-2009: a descriptive study. Am J Prev Med 2014; 46:150-7; PMID:24439348; http://dx.doi.org/10.1016/j.amepre.2013.10.010
  • Global Advisory Committee on Vaccine Safety. Safety of Immunization during Pregnancy: A review of the evidence. 2014.
  • W A. Epidemiology and prevention of vaccine-preventable diseases. 7th ed Atlanta, Ga:Centers for Disease Control and Prevention 2002.
  • Sur DK, Wallis DH, O'Connell TX. Vaccinations in pregnancy. Am Fam Physician 2003; 68:299-304; PMID:12892350
  • D'Acremont V, Tremblay S, Genton B. Impact of vaccines given during pregnancy on the offspring of women consulting a travel clinic: a longitudinal study. J Travel Med 2008; 15:77-81; PMID:18346239; http://dx.doi.org/10.1111/j.1708-8305.2007.00175.x
  • Tana MM, Hoofnagle JH. Scar undone: long-term therapy of hepatitis B. Lancet 2013; 381:433-4; PMID:23234726; http://dx.doi.org/10.1016/S0140-6736(12)61721-8
  • Licata A, Ingrassia D, Serruto A, Soresi M, Giannitrapani L, Montalto G, Craxì A, Almasio PL. Clinical course and management of acute and chronic viral hepatitis during pregnancy. J Viral Hepat 2015; 22:515-23; PMID:25288051; http://dx.doi.org/10.1111/jvh.12335
  • Chin TL, MacGowan AP, Jacobson K, Donati M. Viral infections in pregnancy: advice for healthcare workers. J Hosp Infect 2014; 87:11-24; PMID:24767811; http://dx.doi.org/10.1016/j.jhin.2013.12.011
  • Han YT, Sun C, Liu CX, Xie SS, Xiao D, Liu L, Yu JH, Li WW, Li Q. Clinical features and outcome of acute hepatitis B in pregnancy. BMC Infect Dis 2014; 14:368.
  • Whittaker G, Herrera JL. Hepatitis B in Pregnancy. South Med J 2014; 107:195-200; PMID:24937341; http://dx.doi.org/10.1097/SMJ.0000000000000077
  • Patton H, Tran TT. Management of hepatitis B during pregnancy. Nat Rev Gastroenterol Hepatol 2014; 11:402-9; PMID:24686270; http://dx.doi.org/10.1038/nrgastro.2014.30
  • Levy M, Koren G. Hepatitis B vaccine in pregnancy: maternal and fetal safety. Am J Perinatol 1991; 8:227-32; PMID:1827584; http://dx.doi.org/10.1055/s-2007-999384
  • Han GR, Xu CL, Zhao W, Yang YF. Management of chronic hepatitis B in pregnancy. World J Gastroenterol 2012; 18:4517-21; PMID:22969224; http://dx.doi.org/10.3748/wjg.v18.i33.4517
  • Degli Esposti S, Shah D. Hepatitis B in Pregnancy: Challenges and Treatment. Gastroenterol Clin North Am 2011; 40:355-72; PMID:21601784; http://dx.doi.org/10.1016/j.gtc.2011.03.005
  • Arevalo JA. Hepatitis B in pregnancy. West J Med 1989; 150:668-74; PMID:2665319
  • Borgia G, Carleo MA, Gaeta GB, Gentile I. Hepatitis B in pregnancy. World J Gastroenterol 2012; 18:4677-83; PMID:23002336; http://dx.doi.org/10.3748/wjg.v18.i34.4677
  • Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol 2005; 43:771-5; PMID:16139923; http://dx.doi.org/10.1016/j.jhep.2005.05.023
  • Sirilert S, Traisrisilp K, Sirivatanapa P, Tongsong T. Pregnancy outcomes among chronic carriers of hepatitis B virus. Int J Gynaecol Obstet 2014; 126:106-10; PMID:24834849; http://dx.doi.org/10.1016/j.ijgo.2014.02.019
  • Safir A, Levy A, Sikuler E, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver int 2010; 30:765-70; PMID:20214739; http://dx.doi.org/10.1111/j.1478-3231.2010.02218.x
  • Tormans G, Van Damme P, Carrin G, Clara R, Eylenbosch W. Cost-effectiveness analysis of prenatal screening and vaccination against hepatitis B virus-the case of Belgium. Soc Sci Med 1993; 37:173-81; PMID:8351532; http://dx.doi.org/10.1016/0277-9536(93)90453-B
  • Sinha S, Kumar M. Pregnancy and chronic hepatitis B virus infection. Hepatol Res 2010; 40:31-48; PMID:20156298; http://dx.doi.org/10.1111/j.1872-034X.2009.00597.x
  • Ayoola EA, Johnson AOK. Hepatitis-B Vaccine in Pregnancy - Immunogenicity, Safety and Transfer of Antibodies to Infants. Int J Gynaecol Obstet 1987; 25:297-301; PMID:2887464; http://dx.doi.org/10.1016/0020-7292(87)90289-X
  • Bacq Y. Hepatitis B and pregnancy. Gastroenterol Clin Biol 2008; 32:S12-9; PMID:18662605; http://dx.doi.org/10.1016/S0399-8320(08)73260-3
  • Thio CL, Guo N, Xie C, Nelson KE, Ehrhardt S. Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. Lancet Infect Dis 2015; 15:981-5; PMID:26145195; http://dx.doi.org/10.1016/S1473-3099(15)00158-9
  • Gall SA. Maternal immunization to protect the mother and neonate. Expert Rev Vaccines 2005; 4:813-8; PMID:16372877; http://dx.doi.org/10.1586/14760584.4.6.813
  • Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol 2012; 4:74-80; PMID:22489259; http://dx.doi.org/10.4254/wjh.v4.i3.74
  • Kumar A. Hepatitis B virus infection and pregnancy: a practical approach. Indian J Gastroenterol 2012; 31:43-54; PMID:22528342; http://dx.doi.org/10.1007/s12664-012-0174-4
  • Hieu NT, Kim KH, Janowicz Z, Timmermans I. Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years. Vaccine 2002; 20:1803-8; PMID:11906768; http://dx.doi.org/10.1016/S0264-410X(01)00518-7
  • Shivananda, Somani V, Srikanth BS, Mohan M, Kulkarni PS. Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India. Clin Vaccine Immunol 2006; 13:661-4; PMID:16760324; http://dx.doi.org/10.1128/CVI.00087-06
  • Schiff GM, Sherwood JR, Zeldis JB, Krause DS. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents. J Adolesc Health 1995; 16:12-7; PMID:7742331; http://dx.doi.org/10.1016/1054-139X(94)00105-N
  • Hernandez-Bernal F, Aguilar-Betancourt A, Aljovin V, Arias G, Valenzuela C, de Alejo KP, Hernández K, Oquendo O, Figueredo N, Figueroa N, et al. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults. Hum Vaccin 2011; 7:1026-36; PMID:21941089; http://dx.doi.org/10.4161/hv.7.10.15989
  • Van Damme P, Minervini G, Liss CL, McCarson B, Vesikari T, Boslego JW, Bhuyan PK. Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults. Hum Vaccin 2009; 5:92-7; PMID:18690015; http://dx.doi.org/10.4161/hv.5.2.6587
  • Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Hepatitis B vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev 2014; 11:Cd007879; PMID:25385500
  • Gupta I, Ratho RK. Immunogenicity and safety of two schedules of Hepatitis B vaccination during pregnancy. J Obstet Gynaecol Res 2003; 29:84-6; PMID:12755527; http://dx.doi.org/10.1046/j.1341-8076.2002.00076.x
  • Ingardia CJ, Kelley L, Steinfeld JD, Wax JR. Hepatitis B vaccination in pregnancy: factors influencing efficacy. Obstet Gynecol 1999; 93:983-6; PMID:10362167; http://dx.doi.org/10.1016/S0029-7844(98)00563-8
  • Ingardia CJ, Kelley L, Lerer T, Wax JR, Steinfeld JD. Correlation of maternal and fetal hepatitis B antibody titers following maternal vaccination in pregnancy. Am J Perinatol 1999; 16:129-32; PMID:10438194; http://dx.doi.org/10.1055/s-2007-993846
  • Ingardia C, Morgan M, Feldman D, Bobrowski R. Hepatitis B vaccination in pregnancy-factors associated with immunity in subsequent pregnancy. Am J Obstet Gynecol 2003; 189:S102-S; http://dx.doi.org/10.1016/j.ajog.2003.10.135
  • Sheffield JS, Hickman A, Tang J, Moss K, Kourosh A, Crawford NM, et al. Efficacy of an accelerated hepatitis B vaccination program during pregnancy. Obstet Gynecol 2011; 117:1130-5; PMID:21508752; http://dx.doi.org/10.1097/AOG.0b013e3182148efe
  • Sheffield J, Roberts S, Vanessa L, Hickman A, Tang J, Moss K, Kourosh A, Crawford NM, Wendel GD Jr. The efficacy of an accelerated hepatitis B vaccination program during pregnancy. Am J Obstet Gynecol 2006; 195:S73; http://dx.doi.org/10.1016/j.ajog.2006.10.233
  • Grosheide PM, Schalm SW, Vanos HC, Fetter WPF, Heijtink RA. Immune-Response to Hepatitis-B Vaccine in Pregnant-Women Receiving Postexposure Prophylaxis. Eur J Obstet Gynecol Reprod Biol 1993; 50:53-8; PMID:8365536; http://dx.doi.org/10.1016/0028-2243(93)90164-8
  • Anonymous P. Foetal immunoprophylaxis with hepatitis-B vaccine could be a cost effective approach towards eradication in the high-risk population. J Pediatr Gastroenterol Nutr 2005; 40:678.
  • Reddy PA, Gupta I, Ganguly NK. Hepatitis-B vaccination in pregnancy: safety and immunogenic response in mothers and antibody transfer to neonates. Asia Oceania J Obstet Gynaecol 1994; 20:361-5; PMID:7832667; http://dx.doi.org/10.1111/j.1447-0756.1994.tb00482.x
  • World Health Orgnization. Hepatitis B vaccines. Weekly Epid Record 2009; 84:405-20.
  • Evans AA, Cohen C, Huang P, Qian L, London WT, Block JM, Chen G. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative. Vaccine 2015; 33:3010-5; PMID:25698491; http://dx.doi.org/10.1016/j.vaccine.2015.01.054
  • Coonrod DV, Jack BW, Boggess KA, Long R, Conry JA, Cox SN, Cefalo R, Hunter KD, Pizzica A, Dunlop AL. The clinical content of preconception care: immunizations as part of preconception care. Am J Obstet Gynecol 2008; 199:S290-5; PMID:19081423; http://dx.doi.org/10.1016/j.ajog.2008.08.061
  • Lin HC, Liu CC, Liu DP, Huang SE, Huang TM, Wu BH. Impact of universal Hepatitis B vaccination on the prevalence of HBs and HBe antigenemia among pregnant women in Taiwan. Int J Infect Dis 2008; 12:E95-E6; PMID:18768341; http://dx.doi.org/10.1016/j.ijid.2008.05.239
  • Guidelines for hepatitis B virus screening and vaccination during pregnancy. ACOG Committee opinion: Committee on Obstetrics: Maternal and Fetal Medicine. Number 111-May 1992. Int J Gynaecol Obstet 1993; 40:172-4; PMID:8094692; http://dx.doi.org/10.1016/0020-7292(93)90383-8
  • Alavian SM, Fallahian F, Lankarani KB. Implementing strategies for hepatitis B vaccination. Saudi J Kidney Dis Transpl 2010; 21:10-22; PMID:20061687
  • Bozzo P, Narducci A, Einarson A. Vaccination during pregnancy. Can Fam Physician 2011; 57:555-7; PMID:21571717
  • Anselem O, Parat S, Theau A, Floret D, Tsatsaris V, Goffinet F, Launay O. Vaccination and pregnancy. Presse Med 2014; 43:715-21; PMID:24863661; http://dx.doi.org/10.1016/j.lpm.2014.04.003
  • ACOG Practice Bulletin No. 86: Viral Hepatitis in Pregnancy. Obstet Gynecol 2007; 110(4):941-56; PMID:17906043
  • Saindou M, Voirin N, Troalen D, Abaine A, Chevallier-Queyron P, Ecochard R, Vanhems P. Socio-demographic and behavioral determinants of hepatitis B vaccination and infection in pregnant women on Mayotte Island, Indian Ocean. Vaccine 2013; 31:4946-52; PMID:23981433; http://dx.doi.org/10.1016/j.vaccine.2013.08.047
  • Zhang L, Gui XE, Teter C, Zhong HR, Pang ZY, Ding LX, Li F, Zhou Y, Zhang L. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine. Vaccine 2014; 32:6091-7; PMID:25240752; http://dx.doi.org/10.1016/j.vaccine.2014.08.078
  • Zhu Q, Yu G, Yu H, Lu Q, Gu X, Dong Z, Zhang X. A randomized control trial on interruption of HBV transmission in uterus. Chin Med J (Engl) 2003; 116:685-7; PMID:12875680
  • Cheung KW, Seto MTY, Wong SF. Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2013; 169:17-23; PMID:23465469; http://dx.doi.org/10.1016/j.ejogrb.2013.02.001
  • Yue Y, Yang X, Zhang S. Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin: efficacy and mechanism. Chin Med J (Engl) 1999; 112:37-9; PMID:11593638
  • Shi Z, Li X, Ma L, Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis 2010; 14:e622-34; PMID:20106694; http://dx.doi.org/10.1016/j.ijid.2009.09.008
  • Dyson JK, Waller J, Turley A, Michael E, Moses S, Valappil M, Hudson M, Bassendine M, McPherson S. Hepatitis B in pregnancy. Frontline gastroenterol 2014; 5:111-7; PMID:24683447; http://dx.doi.org/10.1136/flgastro-2013-100361
  • Health Do. Green Book: Immunisation against infectious disease. 2006; http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/206232/Green-Book-updated-070513.pdf.
  • Guo Y, Liu JQ, Meng LP, Meina H, Du YK. Survey of HBsAg-positive pregnant women and their infants regarding measures to prevent maternal-infantile transmission. BMC Infect Dis 2010; 10:26; PMID:20156338; http://dx.doi.org/10.1186/1471-2334-10-26
  • Gan L, Liu DY, Wei M, Ke CP, Tang XM, Xiao XM. Mutations of hepatitis B virus S gene by hepatitis B immunoglobulin administration in late pregnancy. African J Microbiol Res 2012; 6:5975-9
  • Jin H, Zhao Y, Tan Z, Zhang X, Zhao Y, Wang B, Liu P. Immunization interventions to interrupt hepatitis B virus mother-to-child transmission: a meta-analysis of randomized controlled trials. BMC Pediatr 2014; 14:307; PMID:25526664; http://dx.doi.org/10.1186/s12887-014-0307-2
  • Xu H, Zeng T, Liu JY, Lei Y, Zhong S, Sheng YJ, Zhou Z, Ren H. Measures to reduce mother-to-child transmission of Hepatitis B virus in China: a meta-analysis. Dig Dis Sci 2014; 59:242-58; PMID:24193353; http://dx.doi.org/10.1007/s10620-013-2918-0
  • Ji HL, Xu S, Chen MN, Chen Y, Deng NX. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in HBe-positive mothers: a meta-analysis. Strait J Pre Med 2008; 14:80-2.
  • Li T, Qiu JM, Miao MH, Su XJ, Duan T. interruption of intrauterine transmission of hepatitis B virus infection with HBIG during late pregnancy : a meta-analysis. Pro Obstet Gynecol 2009; 18:197-200.
  • Zhou BQ. A Meta-analysis of Hepatitis B Immunoglobulin on the Prevention of Intrauterine Infection. Zhejiang J Pre Med 2010; 22:4-6.
  • Wang Q, Jiang X, Wang RG, Yin HX, Cai X. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in HBs-positive mothers: a meta-analysis. World Health Dig Med Per 2013; 10:221-2.
  • Xiao XM, Li AZ, Chen X, Zhu YK, Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet 2007; 96:167-70; PMID:17296201; http://dx.doi.org/10.1016/j.ijgo.2006.11.011
  • Yuan J, Lin J, Xu A, Li H, Hu B, Chen J, Yao J, Dong H, Jiang M. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat 2006; 13:597-604; PMID:16907846; http://dx.doi.org/10.1111/j.1365-2893.2006.00738.x
  • Xu Q, Xiao L, Lu XB, Zhang YX, Cai X. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol 2006; 12:3434-7; PMID:16733865
  • Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission: a clinical study. World J Gastroenterol 2003; 9:1501-3; PMID:12854150; http://dx.doi.org/10.3748/wjg.v9.i7.1501
  • Yue F, Xing QX, Li DR, Deng TM. Clinical observation of blocking intrauterine infection by injection of hepatitis B immunoglobulin before laboring. Chin Clin Med 2003; 19:1049-50
  • Yang J, Li LQ, Deng QW, Huang Z, Yu ZJ, Fan XN. Systematic Review of the Use of Hepatitis B Immune Globulin in Late Pregnancy for the Prevention of Intrauterine Transmission of HBV. Chin Med Res 2014; 12:146-9
  • Yeung CY, Lee HC, Chan WT, Jiang CB, Chang SW, Chuang CK. Vertical transmission of hepatitis C virus: Current knowledge and perspectives. World J hepatol 2014; 6:643-51; PMID:25276280; http://dx.doi.org/10.4254/wjh.v6.i9.643
  • Arshad M, El-Kamary SS, Jhaveri R. Hepatitis C virus infection during pregnancy and the newborn period–are they opportunities for treatment? J Viral Hepat 2011; 18:229-36; PMID:21392169; http://dx.doi.org/10.1111/j.1365-2893.2010.01413.x
  • Prasad MR, Honegger JR. Hepatitis C virus in pregnancy. Am J Perinatol 2013; 30:149-59; PMID:23389935; http://dx.doi.org/10.1055/s-0033-1334459
  • Rimon E, Lurie Y, Bass DD, Levi S. Acute hepatitis C during pregnancy. Case report and review of the literature. Arch Gynecol Obstet 1998; 262:95-7; PMID:9836008; http://dx.doi.org/10.1007/s004040050235
  • Chen PH, Limketkai BN, Kim B, Woreta TA. Effects of chronic hepatitis C on pregnancy and perinatal outcomes. Hepatology 2013; 58:216A.
  • Huang QT, Huang Q, Zhong M, Wei SS, Luo W, Li F, Yu YH. Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies. J Viral Hepat 2015; 22(12):1033-42
  • Pergam SA, Wang CC, Gardella CM, Sandison TG, Phipps WT, Hawes SE. Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol 2008; 199:38.e1-9; PMID:18486089; http://dx.doi.org/10.1016/j.ajog.2008.03.052
  • Reddick KL, Jhaveri R, Gandhi M, James AH, Swamy GK. Pregnancy outcomes associated with viral hepatitis. J Viral Hepat 2011; 18:e394-8; PMID:21692952; http://dx.doi.org/10.1111/j.1365-2893.2011.01436.x
  • Le Campion A, Larouche A, Fauteux-Daniel S, Soudeyns H. Pathogenesis of hepatitis C during pregnancy and childhood. Viruses 2012; 4:3531-50; PMID:23223189; http://dx.doi.org/10.3390/v4123531
  • Zahran KM, Badary MS, Agban MN, Abdel Aziz NH. Pattern of hepatitis virus infection among pregnant women and their newborns at the Women's Health Center of Assiut University, Upper Egypt. Int J Gynaecol Obstet 2010; 111:171-4; PMID:20708181; http://dx.doi.org/10.1016/j.ijgo.2010.06.013
  • Sogni P. Pregnancy and viral hepatitis B and C. Presse Med 2015; 44:654-9; PMID:26033559; http://dx.doi.org/10.1016/j.lpm.2015.04.018
  • Pappalardo BL. Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis. Int J Epidemiol 2003; 32:727-34; PMID:14559740; http://dx.doi.org/10.1093/ije/dyg107
  • Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, Butler K. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000; 356:904-7; PMID:11036896; http://dx.doi.org/10.1016/S0140-6736(00)02681-7
  • Foster GR, Tudor WG, White J, Regan L. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. BJOG 2001; 108:371-7; PMID:11305543
  • Marine-Barjoan E, Berrebi A, Giordanengo V, Favre SF, Haas H, Moreigne M, Izopet J, Tricoire J, Tran A, Pradier C, et al. HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus? Aids 2007; 21:1811-5; PMID:17690581; http://dx.doi.org/10.1097/QAD.0b013e3282703810
  • Kimberly A, Workowski GAB. Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recomm Rep 2015; 64:17-9
  • Mikulich VJ, Schriger DL. Abridged version of the updated US Public Health Service guidelines for the management of occupational exposures to hepatitis B virus, hepatitis C virus, and human immunodeficiency virus and recommendations for postexposure prophylaxis. Ann Emerg Med 2002; 39:321-8; PMID:11867990; http://dx.doi.org/10.1067/mem.2002.393321
  • Lam NCV, Gotsch PB, Langan RC. Caring for Pregnant Women and Newborns, with Hepatitis B or C. Am Fam Physician 2010; 82:1225-9; PMID:21121533
  • Rizzetto M. Hepatitis D Virus: Introduction and Epidemiology. Cold Spring Harb Perspect Med 2015; 5:a021576; PMID:26134842; http://dx.doi.org/10.1101/cshperspect.a021576
  • He W, Ren B, Mao F, Jing Z, Li Y, Liu Y, Peng B, Yan H, Qi Y, Sun Y, et al. Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide. PLoS Pathog 2015; 11:e1004840; PMID:25902143; http://dx.doi.org/10.1371/journal.ppat.1004840
  • Farci P, Niro GA. Clinical features of hepatitis D. Semin Liver Dis 2012; 32:228-36; PMID:22932971; http://dx.doi.org/10.1055/s-0032-1323628
  • Negro F. Hepatitis D virus coinfection and superinfection. Cold Spring Harb Perspect Med 2014; 4:a021550; PMID:25368018; http://dx.doi.org/10.1101/cshperspect.a021550
  • Rizzetto M, Alavian SM. Hepatitis delta: the rediscovery. Clin Liver Dis 2013; 17:475-87; PMID:23905817; http://dx.doi.org/10.1016/j.cld.2013.05.007
  • World Health Orgnization. hepatitis Delta. 2001.
  • Goyal A, Murray JM. The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology. PLoS One 2014; 9:e110143; PMID:25313681; http://dx.doi.org/10.1371/journal.pone.0110143
  • Teshale EH, Hu DJ. Hepatitis E: Epidemiology and prevention. World J hepatol 2011; 3:285-91; PMID:22216368; http://dx.doi.org/10.4254/wjh.v3.i12.285
  • Devarbhavi H, Kremers WK, Dierkhising R, Padmanabhan L. Pregnancy-associated acute liver disease and acute viral hepatitis: Differentiation, course and outcome. J Hepatol 2008; 49:930-5; PMID:18926590; http://dx.doi.org/10.1016/j.jhep.2008.07.030
  • Shalimar, Acharya SK. Hepatitis E and acute liver failure in pregnancy. J Clin Exp Hepatol 2013; 3:213-24; PMID:25755503; http://dx.doi.org/10.1016/j.jceh.2013.08.009
  • Teo CG. Fatal outbreaks of jaundice in pregnancy and the epidemic history of hepatitis E. Epidemiol Infect 2012; 140:767-87; PMID:22273541; http://dx.doi.org/10.1017/S0950268811002925
  • Shrestha SM. Hepatitis E in Nepal. Kathmandu Univ Med J (KUMJ) 2006; 4:530-44; PMID:18603971
  • Aggarwal R, Jameel S. Hepatitis E. Hepatology 2011; 54:2218-26; PMID:21932388; http://dx.doi.org/10.1002/hep.24674
  • Shrestha P, Bhandari D, Sharma D, Bhandari BP. A study of viral hepatitis during pregnancy in Nepal Medical College Teaching Hospital. Nepal Med Coll J 2009; 11:192-4; PMID:20334069
  • Shinde N, Patil T, Deshpande A, Gulhane R, Patil M, Bansod Y. Clinical profile, maternal and fetal outcomes of acute hepatitis e in pregnancy. Ann Med Health Sci Res 2014; 4:S133-9; PMID:25184080; http://dx.doi.org/10.4103/2141-9248.138033
  • Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007; 147:28-33; PMID:17606958; http://dx.doi.org/10.7326/0003-4819-147-1-200707030-00005
  • Gou AL WL, Ma XZ, Zhou YC, AN WR, Mi JT, Liu ZE,et al. A epidemiological study of enterically transmitted non-A, non-B hepatitis in Xinjiang,China. Chin J Public Health 1989; 5:193-9.
  • Ahmed RE, Karsany MS, Adam I. Brief report: acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women. J Med Virol 2008; 80:1747-8; PMID:18712815; http://dx.doi.org/10.1002/jmv.21284
  • Labrique AB, Sikder SS, Krain LJ, West KP, Jr., Christian P, Rashid M, Nelson KE. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 2012; 18:1401-4; PMID:22931753; http://dx.doi.org/10.3201/eid1809.120241
  • Gurley ES, Halder AK, Streatfield PK, Sazzad HMS, Huda TMN, Hossain MJ, Luby SP. Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: possible role of hepatitis E infection. Am J Public Health 2012; 102:2248-54; PMID:23078501; http://dx.doi.org/10.2105/AJPH.2012.300749
  • Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012; 55:988-97; PMID:22121109; http://dx.doi.org/10.1002/hep.25505
  • Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 2003; 70:37-9; PMID:12619951; http://dx.doi.org/10.1007/BF02722743
  • Khuroo MS, Kamili S, Khuroo MS. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat 2009; 16:519-23; PMID:19228284; http://dx.doi.org/10.1111/j.1365-2893.2009.01101.x
  • Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995; 345:1025-6; PMID:7723501; http://dx.doi.org/10.1016/S0140-6736(95)90761-0
  • Emerson SU, Purcell RH. Recombinant vaccines for hepatitis E. Trends Mol Med 2001; 7:462-6; PMID:11597521; http://dx.doi.org/10.1016/S1471-4914(01)02106-2
  • Safary A. Perspectives of vaccination against hepatitis E. Intervirology 2001; 44:162-6; PMID:11509877; http://dx.doi.org/10.1159/000050043
  • Shrestha MP, Scott RM, Joshi DM, Mammen MP, Jr., Thapa GB, Thapa N, Myint KS, Fourneau M, Kuschner RA, Shrestha SK, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356:895-903; PMID:17329696; http://dx.doi.org/10.1056/NEJMoa061847
  • Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376:895-902; PMID:20728932; http://dx.doi.org/10.1016/S0140-6736(10)61030-6
  • Zhang J, Liu CB, Li RC, Li YM, Zheng YJ, Li YP, Luo D, Pan BB, Nong Y, Ge SX, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 2009; 27:1869-74; PMID:19168109; http://dx.doi.org/10.1016/j.vaccine.2008.12.061
  • Nelson KE, Shih JW, Zhang J, Zhao Q, Xia N, Ticehurst JR, Labrique AB. Hepatitis E vaccine to prevent morbidity and mortality during epidemics. Open Forum Infect Dis 2014; 1:ofu098; PMID:25734166; http://dx.doi.org/10.1093/ofid/ofu098
  • Li SW, Zhao Q, Wu T, Chen S, Zhang J, Xia NS. The development of a recombinant hepatitis E vaccine HEV 239. Hum Vaccin Immunother 2015; 11:908-14; PMID:25714510; http://dx.doi.org/10.1080/21645515.2015.1008870
  • Wu T, Zhu FC, Huang SJ, Zhang XF, Wang ZZ, Zhang J, Xia NS. Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis. Hepatology 2012; 55:2038; PMID:22161542; http://dx.doi.org/10.1002/hep.25522
  • Khuroo MS, Dar MY. Hepatitis E: evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol 1992; 11:113-6; PMID:1506045
  • Joshi YK, Babu S, Sarin S, Tandon BN, Gandhi BM, Chaturvedi VC. Indian J Med Res The Indian journal of medical research 1985; 81:18-9; PMID:3921458
  • Arankalle VA, Chadha MS, Dama BM, Tsarev SA, Purcell RH, Banerjee K. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. J Viral Hepat 1998; 5:199-204; PMID:9658374; http://dx.doi.org/10.1046/j.1365-2893.1998.00096.x
  • Joshi SS, Arankalle VA. Enhanced humoral response in pregnant mice immunized with liposome encapsulated recombinant neutralizing epitope protein of Hepatitis- E virus. Virol J 2015; 12:70; PMID:25935713; http://dx.doi.org/10.1186/s12985-015-0302-8
  • Jimenez de Oya N, Alonso-Padilla J, Blazquez AB, Escribano-Romero E, Escribano JM, Saiz JC. Maternal transfer of antibodies to the offspring after mice immunization with insect larvae-derived recombinant hepatitis E virus ORF-2 proteins. Virus Res 2011; 158:28-32; PMID:21376089; http://dx.doi.org/10.1016/j.virusres.2011.02.019
  • Li TC, Suzaki Y, Ami Y, Tsunemitsu H, Miyamura T, Takeda N. Mice are not susceptible to hepatitis E virus infection. J Vet Med Sci 2008; 70:1359-62; PMID:19122406; http://dx.doi.org/10.1292/jvms.70.1359
  • Guo Y, Zhang W, Zhang Y, Lin XF, Zhang B, Chen C, Du Y. Cost-effectiveness analysis of preventing mother-to-child transmission of hepatitis B by injecting hepatitis B immune globulin. Eur J Gastroenterol Hepatol 2012; 24:1363-9; PMID:22922527; http://dx.doi.org/10.1097/MEG.0b013e32835847c6
  • Burroughs AK. Pregnancy and liver disease. Forum (Genova) 1998; 8:42-58.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.